Objective: Inadequate intakes of micronutrients in elderly negatively affect the nutritional status. Zinc is an essential micronutrient in the elderly, especially in relation to its impact on immune function, bone mass, cognitive function and oxidative stress. However, data are lacking on zinc intake and status during normal ageing. In this study, we evaluate the intake and status of zinc in late middle-aged and older free-living subjects. Design: Dietary zinc intake and zinc status in 188 middle-aged subjects from Clermont-Ferrand (Fr) and Coleraine (UK), and in 199 older subjects from Grenoble (Fr) and Roma (It) were assessed at the entry in the ZENITH study. Results: In relation to the zinc RDA for people older than 55 y, zinc intakes in most of the middle-aged and older subjects (more than 96%) in the present study were adequate. Older people had significantly lower (Po0.01) energy intakes as compared to middle-aged. Zinc intake expressed per MJ was also significantly (Po0.01) higher in older people compared to middle-aged. Erythrocyte and urinary zinc concentrations were significantly (Po0.001) higher in middle-aged subjects compared to older ones. The prevalence of biological Zn deficiency in free-living ageing European people was low (o5%).
Introduction
The nutritional requirements of older subjects is an area of great interest because the extended life expectancy leads to an increase in subjects living into their 1980s, and older (Van Grevenhof & Funderburg, 2003; Chernoff, 2005) . Among the micronutrients, Zinc (Zn) is essential in the elderly regarding its impact on immune functions (Bogden, 2004) , age-related changes on bone mass (Lowe et al, 2002) , cognitive functions (Mocchegiani et al, 2005) and oxidative stress (Mocchegiani et al, 2004; Dittmann et al, 2005) . Its role in healthy ageing is also particularly important as it prevents neoplastic cell growth and is involved in DNA and RNA repair (Tudor et al, 2005) .
The elderly are at greater risk of deficiency than younger adults as a result of multiple physiological, social, psychological and economic factors (Drewnowski & Shulz, 2001; McClain et al, 2002) . Our group recently reported decreased Zn pools in free-living or institutionalised older, but this was dependent on lifestyle factors (Faure et al, 2005) . In institutionalised or hospitalised aged people, a high prevalence of Zn deficiency is well documented by several European studies (Schmuck et al, 1996; Girodon et al, 1999; Pepersack et al, 2001) . However, for free-living older subjects (over 70 y), little research has been conducted, specifically regarding zinc intakes, status and specific needs (Sibai et al, 2003) . Providing information about dietary habits of freeliving older subjects, and their possible consequences on the incidence of Zn deficiency in this group, would be useful for the determination of specific needs in relation to Zn in such a population.
Therefore, the aim of this work was to describe and compare, as a part of the ZENITH study, Zn intakes and status in two groups of European subjects (n ¼ 387) recruited for the ZENITH study, older free-living people (aged 70 þ y) and freeliving middle-aged people (55-70 y).
Subjects and methods

Subjects
A total of 387 volunteers participated in the large European study ZENITH. In all, 188 aged 55-70 y (61.874.4 y), recruited from Clermont-Ferrand (France) (n ¼ 95) and Coleraine (United Kingdom) (n ¼ 93) constituted the late middle-aged group, and 199 aged 70-85 y (74.473.8 y), recruited from Grenoble (France) (n ¼ 91) and Rome (Italy) (n ¼ 108) constituted the older group. The recruitment and screening procedures, inclusion/exclusion criteria, and ethical considerations for volunteers participating in this study are described elsewhere in this Supplement (Polito et al, 2005) .
Biological measurements
All blood samples were collected after a 12-h overnight fast. For zinc determination, blood was collected using trace element-free Vacutainer s tubes. Samples were kept on ice immediately after drawing, and then centrifuged at 1000 Â g for 15 min at 41C. Serum Zn and erythrocytes were immediately isolated, aliquoted and stored at À801C.
Serum, erythrocyte and urinary zinc levels were determined by flame atomic absorption spectrometry using previously described methods (Arnaud et al, 1985 (Arnaud et al, , 1986 . Seronorm s trace element serum was used as internal quality control (Sero s , Billingstad, Norway).
Dietary intakes
Dietary intakes were collected by trained personnel using the 4-day recall-record method. Each participant was asked to record all the foods and drinks consumed, describing the foods and portion sizes in as much details as possible. Portion sizes were related on standard portion sizes using a visual book reference with standard of foods. (SU.VI. MAX, 1994; DietroMetro, 1999; Savanvitch et al, 2005) . Food consumption data were converted into energy and macro and micronutrients, by country specified food composition tables.
Statistical analysis
Data are presented as mean7standard deviations. Data for all variables were normally distributed and allowed for parametric tests of significance. Statistical analysis were based on an ANOVA followed by a Newman-Keuls test and Pearson's correlation test. The limit of statistical significance was set at Po0.05.
Results
Zinc intakes
Zinc intake between middle-aged and older people was not significantly different (Table 1 ). In the middle-aged group, Zn intake was significantly higher (Po0.05) in men as compared to women. No significant difference in Zn intake was observed between men and women for the older group. The percentage of subjects who met below 2/3 of the European RDA for people older than 55 y (ie 6.37 mg/day for men and 4.69 mg/day for women) was 3.20% in middleaged subjects (3.20% for males, 3.15% for females) and 3.55% in older subjects (3.55% for males, 0% for females). Expressed on a MJ food energy basis, Zn intake was 1.2970.38 mg/MJ in middle-aged vs 1.4170.76/MJ in older. Zinc intakes, expressed on a MJ basis, were significantly (Po0.0001) higher in older people compared to middleaged, but there were no significant gender differences (ie between middle-aged women and older women, and between middle-aged men and older men).
Zinc status Serum zinc was not significantly different between middleaged and older subjects, between men and women into the two age-groups, and or between countries ( Table 2 ). The percentage of subjects, presenting a serum Zn concentration below 10.7 mmol/l, which is usually considered as the cutoff level for zinc deficiency, was 4.8% in middle-aged (6.4% men, 3.1% women) and 5.6% in older subjects (4.9% men, 6.2% women). Erythrocyte zinc concentration was significantly (Po0.001) higher in middle-aged subjects compared to older subjects. Middle-aged men had a significantly (Po0.01) higher mean erythrocyte zinc concentration compared to older-aged men. Urinary zinc concentration was significantly (Po0.001) higher in the older age-group compared to middle-aged subjects. This age-related difference was also observed within the genders, which was significant both between middle-aged and older women (Po0.001) and middle-aged and older men (Po0.001).
The relationships between indices of zinc nutritive status are shown in Table 3 . Zinc intake was positively correlated (Po0.05) with serum zinc concentration, but not with erythrocyte zinc concentration. Serum zinc concentration was positively correlated (Po0.05) with urinary zinc concentration. Serum zinc concentration was not significantly correlated with erythrocyte zinc concentration.
Discussion
Older people represent a rapidly growing segment of the population in European countries, which is frequently affected by nutrition-related problems (De Groot et al, 1996) . Numerous clinical and epidemiological data focused on the importance of nutritional status in maintaining performance capacities and quality of life in ageing population (Roussel & Ferry, 2002) . Nutritional deficiencies resulting in an increased incidence of age-related pathologies are well documented in ageing (Meydani, 2001) . As zinc nutriture affects oxidative stress, immunity and cognitive functions (Prasad et al, 2004) , it is essential to maintain or to restore an optimal Zn status in ageing and to prevent zinc deficiency in elderly people. Most of the studies in elderly which assessed the prevalence of Zn deficiencies were among hospitalised elderly, or focussed solely on the relationship between Zn status and humoral immune function in ageing (Pepersack et al, 2001 ). Inadequate Zn intakes as well as alterations of Zn status have been especially demonstrated in hospitalised people (Schmuck et al, 1996) . However, data on Zn intakes and status in elderly free-living people and within normal ageing are scarce. Thus, the objectives of this study were : (i) to assess the prevalence of Zn deficiencies in an European elderly population, and (ii) to evaluate the effect of age on Zn intake and status. The older participants were therefore selected as free-living, apparently healthy (aged 70 þ y), while the middle-aged group was selected to represent a general European middle-aged population.
We did not observe an age-related change in Zn intakes between middle-aged subjects (10.9973.98 mg/day) and older subjects (11.3275.16 mg/day). The percentage of subjects who met below 2/3 of the European RDA for people older than 55 y (ie 6.37 mg/day for men and 4.69 mg/day for women) was 3.20% in middle-aged subjects (3.20% for males, 3.15% for females) and 3.55% in older subjects (3.55% for males, 0% for females). Expressed on a MJ food energy basis, Zn intake was 1.2970.38 mg/MJ in middleaged vs 1.4170.76/MJ in older. The nutrient density was significantly higher in older than in middle-aged and close to the Adequate Nutrient Density, 1.89, calculated to allow recommendations to be met with an energy intake of 6.36 MJ/day (Schmuck et al, 1996) . Therefore, this data suggests Zn intakes in this older free-living population are There is no significant sex difference for the three mentioned Zinc status parameters in middle-and older-aged subjects. largely adequate. Indeed, the mean daily Zn intakes reported here are higher than the intakes measured in a previous study older French men, using duplicate diets (Pelus et al, 1994) . They were also higher than those measured from the Third National Health And Nutrition Examination Survey (NHANES), which showed that people older than 71 y (n ¼ 2623) had a mean dietary Zn intake (ie from food sources only) of 9.2 mg/day and the total daily Zn intake rose to 12.7 mg/day when Zn from supplements were accounted for (Paik et al, 1999) . In middle-aged, but not in older, women Zn intake was lower compared to men (10.0574.48 mg/day vs 11.9773.11 mg/day, Po0.0001), reflecting gender-specific differences in dietary habits. Men consume more meat and animal protein, source of Zn than women. Then, with advancing age, this difference trends to decline. The similar Zn intakes in the two age-groups could explain why we did not observe significant differences in Zn status (serum and erythrocyte) between middle-aged and older subjects. It is generally recognized that plasma/serum and erythrocyte Zn are not the ideal biological indicators of Zn status, but taking into account both analytical and physiological criteria, they remain the most informative and easy to use. Serum Zn concentrations have been reported to be negatively correlated with age in some (Hotz et al, 2003) but not all (Del Corso et al, 2000) studies, and decreased serum Zn concentration have been reported in the serum of elderly people 490 y compared to 65-89 y old (Ravaglia et al, 2000) . In the present work, the serum Zn levels in middle-aged and older subjects were 12.9871.50 and 13.2171.72 mmol/l, respectively, and in the same range as those found in others studies from the NHANES II study in 1976 -1980 (Hotz et al, 2003 , which reported an average serum zinc concentration of 13.3 mmol/l for men and 12.5 mmol/l for women. The data from the present study agree also with the AREDS study (2002) which reported serum Zn levels of 12.5 mmol/l for women and 13.0 mmol/l for men. Furthermore, values obtained in middle-aged French women in this study (12.9371.56 mmol/l) are very close to those reported in similarly-aged women from the SU.VI.MAX study (12.8371.85 mmol/l) (Andriollo et al, 2005) and are slightly higher than values obtained for premenopausal women in France (12.171.2 mmol/l; Bureau et al, 2002) or in the United States 11.5 mmol/l (King et al, 1994) . In the older group, serum Zn concentration was not different (13.1073.11 mmol/l for women and 13.1072.97 mmol/l for men) and in agreement with Ravaglia et al (2000) who reported 13.7871.67 mmol/l for a population aged 65-89 y old. Finally, our data confirm the Rancho Bernardo study (Hyun et al, 2004) in which, for a mean dietary intake of 11.274.3 mg (in 396 men-aged 45-92 y), the mean serum Zn concentration was 12.770.1 mmol/l.
The percentage of subjects presenting a serum Zn concentration below 10.7 mmol/l, which is usually considered as the cutoff level for Zinc deficiency, was 4.8% in middle-aged (6.4% men, 3.1% women) and 5.6% in older subjects (4.9% men, 6.2% women). These data suggest a low prevalence of Zn deficiency in free-living ageing European people. This low prevalence of Zn deficiency in a free-living elderly population confirms previous data from others studies which report prevalence at 5% in a study in Boston and 3-4% in EuronutSeneca European-based study (Bailey et al, 1997) , but are very different from data reported in hospitalised elderly, in which 28% (Pepersack et al, 2001) or 38% had plasma Zn below the cutoff value of deficiency (Schmuck et al, 1996) .
In our population, we did not observe gender differences for Zn status, which is in line with the similar findings in a number of studies (Rukgauer et al, 1997; Paik et al, 1999; Diaz Romero et al, 2002) . However, Schumacher et al (1994) reported a higher serum mean Zn concentration in female subjects. Differences in serum zinc concentration according to gender have been attributed to sex hormones. The age of the subjects in the present study, together with their probable low hormonal status, may explain why a gender difference in Zn status was not observed.
Zn urinary excretion tended to be higher in older subjects than in middle-aged (1.0370.81 vs 0.6570.30 mmol/mmol creatinine), suggesting that Zn metabolism might be altered with ageing.
Conclusions
We observed a low prevalence of Zn deficiencies in healthy late middle-aged and older subjects living at home. These older European subjects for the most part had adequate Zn intakes. These data on European population are consistent with data from other studies performed in US, underlying similar habits in Zn intake in developed countries. Consequently, these descriptive results should be useful for health professionals to have reference data on Zn intake and status for a healthy ageing.
